CurifyLabs’ PharmaPrinter Aurum is a pioneering device to compound personalized medicines in pharmacies. Aurum enables precise, safe, and Pharmacopeia-compliant production of personalized medicine. Its patented syringe attachment and modular hot-end ensure efficient operation, while built-in balance delivers automated mass uniformity for each dispensed.
Modular adapters support compounding of a variety of dosage forms, such as tablets, films, suppositories, and troches. The UV-protected shell offers visibility and API protection, with materials and form factors designed for easy cleaning, sterilization, and durable, dust-protected operation. PharmaPrinter Aurum has increased social benefit as it enables precise, safe, and Pharmacopeia-compliant production of personalized medicine, addressing the gap where off-the-shelf drugs cannot meet the patient requirements.
By automating compounding, Aurum reduces human error and ensures accurate dosing for children and patients with special requirements. The validated process uses APIs straight from medicine factories, minimizing the waste and saving energy through single manufacturing processes compared to traditional compounding methods where existing drugs are first ground, reprocessed, and finally dispensed (API compounded twice).





Details
Design
Studio Aslak Siimes, Finland
Manufacturer
CurifyLabs, Finland
Year of production
2026
